|
|||||
|
|
Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment,a phase Ib‐randomized phase II study Commence |
|
| Authors: | Janneke C. Ham Esther van Meerten W. Edward Fiets Laurens V. Beerepoot Frank J. F. Jeurissen Marije Slingerland Marianne A. Jonker Olga Husson Winette T. A. van der Graaf Carla M. L. van Herpen |
| Abstract: | |
| Keywords: | cetuximab first‐line methotrexate palliative treatment recurrent or metastatic squamous cell carcinoma of the head and neck |